Actively Recruiting
Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy - The ALINET Registry
Led by Federico II University · Updated on 2026-01-29
1500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating how well patients with hypercholesterolaemia in Italy stick to and respond to treatment with alirocumab 300 mg. This observational study focuses on patients receiving this medication in real-life settings to better understand adherence, persistence, and treatment effectiveness over time. Participants in this study are patients already taking alirocumab 300 mg injections. The study observes their treatment without assigning interventions, tracking outcomes over periods of 6, 12, 24, and 36 months to assess adherence, persistence, and efficacy of the medication. During the study, researchers will collect data at regular intervals up to 36 months to evaluate treatment adherence, persistence, efficacy, and safety. Participants' ongoing treatment will be monitored through clinical assessments and records, with no additional treatment required as part of the study. The total participation time can last up to three years.
CONDITIONS
Brief Title
Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients under alirocumab 300mg treatment.
You will not qualify if you...
- Age less than 18 years or greater than 80 years.
- Patients who refuse to participate and to sign informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 36 months
Participants receive Alirocumab 300 mg injections as part of their treatment for hyperlipidaemia.
Visits may occur at 6, 12, 24, and 36 months to assess adherence, persistence, efficacy, and safety.
Trial Site Locations
Total: 1 location
1
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Napoli, Italy, 80131
Actively Recruiting
Research Team
P
Pasquale Perrone Filardi
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here